Mdxhealth GPS
Active Awarded Last action
- Contract number
- 36C25726N0254
- Awardee
-
Mdxhealth, Inc. UEI LQGYDJJ9K8Q6
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $15,965
Award facts
- Opportunity
-
- Q301--674-23-3-035-0018 | NEW | CTX MDxHealth GPS Special Notice · 36C25723Q0843 · Posted May 16, 2023
- Contract value 100% obligated
- $15,964.65 Current and potential, with all options
- Completion date 40% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Temple, TX 76504, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17) awarded Mdxhealth, Inc. a $15,964.65 firm fixed price contract call under an existing Blanket Purchase Agreement for Genomic Prostate Score (GPS) testing services. This contract call, with an ultimate completion date of June 4, 2027, represents a delivery order against Mdxhealth's $240,000 BPA for MDXHEALTH GPS services established on May 1, 2023 and extending through June 4, 2028. The contract is issued under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and carries no set-aside designation, allowing Mdxhealth to compete as a standard commercial vendor. Services will be performed at Mdxhealth's facility in Temple, Texas.
Mdxhealth, Inc., a for-profit healthcare company headquartered in Irvine, California, specializes in molecular diagnostic services for cancer testing and analysis. The company maintains an active federal contracting presence with the VA across multiple Veterans Integrated Service Networks, providing advanced genomic and epigenetic testing services to support personalized diagnosis and treatment strategies for veterans. This contract supports the VA's delivery of specialized prostate cancer screening capabilities as part of the broader Veterans Health Administration mission to provide comprehensive healthcare services to the veteran population.
Quick answers
Who was awarded contract 36C25726N0254?
36C25726N0254 was awarded to Mdxhealth, Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on June 5, 2026.
How much is contract 36C25726N0254 worth?
The government has obligated $15,965 on 36C25726N0254.
Is contract 36C25726N0254 an order under another contract?
Yes. 36C25726N0254 is a BPA call under V797D70066-36C25723A0027, a blanket purchase agreement, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C25726N0254 competed?
The extent of competition for 36C25726N0254 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award